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The choice of disease-specific versus generic scales is
common to many fields of medicine. In the area of
traumatic brain injury, evidence is coming forward that
disease-specific prognostic models and disease-specific
scoring systems are preferable in the intensive care
setting. In monitoring prognosis, the use of a calibration
belt in validation studies potentially provides accurate
and intuitively attractive insight into performance. This
approach deserves further empirical evaluation of its
added value as well as its limitations.tic models for moderate and severe TBI have been devel-In the previous issue of Critical Care, Raj and colleagues
[1] report a detailed study on the evaluation of com-
monly employed general ICU scales to predict outcome
in patients with traumatic brain injury (TBI). They com-
pare performance to that of simpler models based on
only age and Glasgow Coma Scale (GCS). The authors
conclude that the simple prognostic model based only
on age and GCS showed fairly good prognostic perform-
ance and that the use of more complex general ICU
scoring systems added little to this. This manuscript
clearly demonstrates that TBI patients in the ICU envir-
onment are a highly specific population, in which gen-
eral ICU scoring systems are of limited value. Second,
from a methodological perspective, it presents and dis-
cusses essential approaches for quantifying the perform-
ance of prognostic models and provides empirical
illustration of the use of a new instrument for assessing
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2014Limited value of general ICU scoring systems in
traumatic brain injury patients
Scoring systems such as the Acute Physiology and
Chronic Health Evaluation II, Simplified Acute Physi-
ology Score II and Sequential Organ Failure Assessment
scores are commonly used in the intensive care setting
to quantify the impact of disease severity and to bench-
mark the quality of delivered health care. These scoring
systems are developed for use in the general ICU envir-
onment and are not disease specific. TBI is a very het-
erogeneous disease in terms of cause, pathology, severity
and also in expected outcome. Disease-specific prognos-
oped and validated. These include the CRASH
(Corticosteroid Randomisation After Significant Head
Injury) [2] and the IMPACT (International Mission for
Prognosis and Analysis of Clinical Trials in TBI) [3]
prognostic models. Both the IMPACT and CRASH
models have shown reasonable to good performance at
external validation, both for mortality and 6-month
Glasgow Outcome Scale. The latter is particularly im-
portant as the degree of functional recovery in the long
term is perhaps even more relevant than early mortality
in TBI patients. The IMPACT studies have shown that
most prognostic information is contained within three
variables: age, GCS motor score, and pupillary reactivity
[4]. The findings on age and GCS in the present study
are in line with this observation. Apparently the add-
itional information from many parameters obtained at
admission (as in the IMPACT model) or during the first
24 hours of care (as for ICU-specific models) adds little
prognostic value compared to core information such as
age and admission GCS. Further development and valid-
ation of TBI-specific prediction models is required, in-
cluding disease-specific information that becomes
available during the clinical course. The latter will re-
quire a dynamic prediction framework [5].Central Ltd. The licensee has exclusive rights to distribute this article, in any
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The performance of prognostic models is commonly
evaluated by discrimination and calibration. Discrimin-
ation concerns the ability to distinguish between survival
and death or favourable and unfavourable outcome. It is
generally assessed by calculating the area under the re-
ceiver operating characteristic curve (AUC). Discrimin-
ation is influenced by both the validity of the model for
a specific population (that is, the statistical fit of the
model) and the case mix of the validation population
[6,7]. If the population includes subsets with a more ex-
treme prognosis (for example, mild versus severe TBI),
the discriminative ability will be boosted upwards. For
this reason, a case mix adjusted AUC has been proposed
[6]. In the present study, a more homogeneous popula-
tion may have lowered the discriminative ability of the
ICU-specific models.
Calibration evaluates the agreement between observed
and predicted outcome and can be graphically presented
in plots. The often used Hosmer-Lemeshow test con-
siders deciles of patients with similar risk, and reflects
the average concordance of expected outcome compared
to the observed outcome analyzed. Limitations of the
Hosmer-Lemeshow test mentioned by the authors in-
clude that it may be non-informative in large data sets
(that is, statistically significant for minor miscalibration),
and that the division of the patient cohort into deciles
does not account sufficiently for the individual patient.
As a relatively new instrument to assess calibration,
the authors utilised a calibration belt. This approach was
developed and tested within the GiViTI consortium in
Italy (Italian Group for the evaluation of interventions in
intensive care medicine) and was taken forward in a lar-
ger ICU network named Prosafe through EU funding
(PHEA 2007 331). These studies are now coordinated in
the CREACTIVE Project (prospective longitudinal data
collection and comparative effectiveness research for
TBI). Within this project, TBI-specific prognostic
models will be developed to be used as a benchmark for
quality of care assessment in individual ICUs. The cali-
bration belt relates the observed and the expected prob-
ability of a dichotomised outcome. Importantly, the
calibration belt calculates the 80% confidence interval
and the 95% confidence interval surrounding the calibra-
tion curve. This instrument thus potentially provides ac-
curate and intuitively attractive insight into calibration
performance. As with any new instrument, however, its
validity has to be demonstrated in broad settings and
validated by other groups. Limitations may only become
apparent with greater experience. It is not quite clear
how dependent the calibration belt and, in particular,
the calculated confidence interval may be upon the rela-
tive number of patients with specific prognostic risks.Adding the distribution of patient numbers across the
plotted curves would provide additional insight. Not-
withstanding this potential limitation, this approach in
which disease-specific aspects are combined in an intui-
tively attractive novel instrument is worthy of further ex-
ploration and validation.
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